The University of Pennsylvania officially opened its new Translational Research Center on May 17. The TRC is the first medical research building on the Penn campus - and one of the first anywhere - to be physically integrated into facilities for patient care, namely the Perelman Center for Advanced Medicine and the Roberts Proton Therapy Center. The first of several hundred researchers began moving into the $370-million facility in April.
TRC will now be the home for three Penn institutes created in early 2005: the Institute for Diabetes, Obesity, and Metabolism; the Institute for Translational Medicine and Therapeutics; and the Penn Cardiovascular Institute.
The annual Bio International Convention is set for June 27-30, in Washington, D.C., at the Walter E. Washington Convention Center. For a detailed look at the schedule, featured sessions and other pertinent information, click here.
The U.S. Dept. of Commerce will lead a Biotech Life Sciences Trade Mission to Beijing and Hong Kong Oct. 17-20, 2011. The mission will allow U.S. biotech executives to meet with Chinese government officials and pre-screened potential partners in both cities.
Participants will receive briefings by high-ranking U.S. Embassy officials and industry experts on biotech opportunities and regulatory issues in China and Hong Kong. Hong Kong is a rapidly developing center of excellence in the biotech sector, and offers U.S. companies fantastic opportunities to partner with companies with strong contacts in the Chinese mainland. For more information, contact Commercial Officer Doug Wallace or Jay Biggs. Pre-register for the trade mission.
A survey by the North Carolina Biosciences Organization shows that N.C. life sciences companies brought in more than $1.1 million in investments and grants during the 12-month period ending April 25, 2011.
A U.S. medical product manufacturer is expanding in Ireland. Harmac Medical Products says it will add 100 jobs at its operations in Castlerea. Harmac, which is based in Buffalo, also operates a facility in Mexico.
A recent report by Battelle indicates that the federal investment in the Human Genome Project has created 310,000 jobs and promises to create many more in the future. The project has had a nearly $800-billion economic impact.
Metabolon, a Durham, N.C.-based life sciences company founded in 2000, has experienced rapid growth the past two years and has plans for continued expansion.